TP53 and B-cell chronic lymphocytic leukemia: Among the novel genetic alterations disclosed by whole genome/exome sequencing, NOTCH1, SF3B1 and BIRC3 lesions follows the same distribution across CLL clinical phases as TP53 and ATM abnormalities (Table 1).